rxstat › Shortages › Oxaliplatin

Oxaliplatin shortage status

Shortage anticipated

Source: Health Canada shortage reports · Updated Jul 9, 2026

A shortage of Oxaliplatin is anticipated but not yet confirmed. 1 product(s) have anticipated-shortage reports on file with Health Canada.
Products affected
0 of 6
Reports on file
31

Reports by product

Anticipated
OXALIPLATIN INJECTION, USP
5MG · SOLUTION · DR REDDY'S LABORATORIES LTD
DIN 02458403 · Other (Please describe in comments)
Resolved
OXALIPLATIN INJECTION
5MG · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02436957 · ended Mar 23, 2026 · Demand increase for the drug.
Resolved
OXALIPLATIN INJECTION, USP
5MG · SOLUTION · DR REDDY'S LABORATORIES LTD
DIN 02458403 · ended Oct 3, 2024 · Delay in shipping of the drug.
Resolved
OXALIPLATIN INJECTION, USP
5MG · SOLUTION · DR REDDY'S LABORATORIES LTD
DIN 02458403 · ended Nov 8, 2023 · Other (Please describe in comments)
Discontinued
PMS-OXALIPLATIN
5MG · SOLUTION · PHARMASCIENCE INC
DIN 02437074
Resolved
OXALIPLATIN INJECTION
5MG · SOLUTION · TEVA CANADA LIMITED
DIN 02435071 · ended Aug 4, 2021 · Disruption of the manufacture of the drug.
Resolved
OXALIPLATIN INJECTION
5MG · SOLUTION · TEVA CANADA LIMITED
DIN 02435071 · ended Mar 17, 2021 · Disruption of the manufacture of the drug.
Resolved
OXALIPLATIN INJECTION
5MG · SOLUTION · TEVA CANADA LIMITED
DIN 02435071 · ended Nov 25, 2020 · Disruption of the manufacture of the drug.
Resolved
PMS-OXALIPLATIN
5MG · SOLUTION · PHARMASCIENCE INC
DIN 02437074 · ended Jun 5, 2020 · Disruption of the manufacture of the drug.
Resolved
PMS-OXALIPLATIN
5MG · SOLUTION · PHARMASCIENCE INC
DIN 02437074 · ended Jun 5, 2020 · Disruption of the manufacture of the drug.
Resolved
PMS-OXALIPLATIN
5MG · SOLUTION · PHARMASCIENCE INC
DIN 02437074 · ended Jun 5, 2020 · Disruption of the manufacture of the drug.
Resolved
OXALIPLATIN INJECTION
5MG · SOLUTION · TEVA CANADA LIMITED
DIN 02435071 · ended May 6, 2020 · Disruption of the manufacture of the drug.

Showing 12 of 31 reports. All reports are on file with Health Canada.

What's happening

A manufacturer has told Health Canada it expects supply of Oxaliplatin to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.

Oxaliplatin is classified under “OTHER ANTINEOPLASTIC AGENTS” (ATC L01XA).

Recent changes

Common questions

When will Oxaliplatin be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Oxaliplatin in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (other antineoplastic agents)

Widespread shortageCarboplatin2 of 3 reported products affectedPartial shortageAmsacrine1 of 1 reported products affectedPartial shortageArsenic Trioxide1 of 3 reported products affectedPartial shortageBortezomib3 of 7 reported products affected · est. return Aug 28, 2026Partial shortageEribulin1 of 1 reported products affected · est. return Dec 31, 2026Partial shortageErlotinib3 of 14 reported products affected · est. return Jun 30, 2027

All other antineoplastic agents shortage statuses →

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.